Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Michael

Showing results (41-50 of 975) with videos related to

Pageof 98
Sort By:
Urology Practice|November 9, 2023
Editorial CommentJohn Michael DiBianco, Vincent Bird
Journal of the American Academy of Dermatology|May 17, 2011
Thyroid dermopathy localized to areas of injury and responsive to complete decongestive physiotherapyJohn Michael Bernardi, Janine Malone
Nature Reviews. Drug Discovery|November 1, 2014
The predictive safety testing consortium and the coalition against major diseasesDiane Stephenson, John-Michael Sauer
Environmental Management|January 12, 2020
Toward Active Community Environmental Policing: Potentials and Limits of a Catalytic ModelJohn-Michael Davis, Yaakov Garb
Drug Design, Development and Therapy|July 21, 2021
Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to DateWajd Alkabbani, John-Michael Gamble
Handbook of Clinical Neurology|July 17, 2019
Electrodiagnosis of radiculopathyJohn-Michael Li, Jinny Tavee
JAAPA : Official Journal of the American Academy of Physician Assistants|November 7, 2024
Vonoprazan: A novel agent used in eradicating Helicobacter pylori infectionDelaney Provenza, John Michael Provenza
Behavioral Sciences (Basel, Switzerland)|January 28, 2026
Understanding Self-Restraint in Neurodevelopmental Conditions: A Primer for Assessment and TreatmentKayla Mann, John Michael Falligant
Neurobiology of Learning and Memory|June 18, 2026
Trazodone reduces sign-tracking but not goal-tracking in male Sprague Dawley ratsJohn Michael Holden, Liam Kubitschek
Canadian Journal of Diabetes|December 8, 2022
Prescribing Trends of the Sodium-Glucose Cotransporter-2 Inhibitors Among Different Physician Specialties in Canada (2015-2021)Wajd Alkabbani, John-Michael Gamble
Pageof 98

Showing results (41-50 of 975) with videos related to

Sort By:
Pageof 98
Urology Practice|November 9, 2023
Editorial CommentJohn Michael DiBianco, Vincent Bird
Journal of the American Academy of Dermatology|May 17, 2011
Thyroid dermopathy localized to areas of injury and responsive to complete decongestive physiotherapyJohn Michael Bernardi, Janine Malone
Nature Reviews. Drug Discovery|November 1, 2014
The predictive safety testing consortium and the coalition against major diseasesDiane Stephenson, John-Michael Sauer
Environmental Management|January 12, 2020
Toward Active Community Environmental Policing: Potentials and Limits of a Catalytic ModelJohn-Michael Davis, Yaakov Garb
Drug Design, Development and Therapy|July 21, 2021
Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to DateWajd Alkabbani, John-Michael Gamble
Handbook of Clinical Neurology|July 17, 2019
Electrodiagnosis of radiculopathyJohn-Michael Li, Jinny Tavee
JAAPA : Official Journal of the American Academy of Physician Assistants|November 7, 2024
Vonoprazan: A novel agent used in eradicating Helicobacter pylori infectionDelaney Provenza, John Michael Provenza
Behavioral Sciences (Basel, Switzerland)|January 28, 2026
Understanding Self-Restraint in Neurodevelopmental Conditions: A Primer for Assessment and TreatmentKayla Mann, John Michael Falligant
Neurobiology of Learning and Memory|June 18, 2026
Trazodone reduces sign-tracking but not goal-tracking in male Sprague Dawley ratsJohn Michael Holden, Liam Kubitschek
Canadian Journal of Diabetes|December 8, 2022
Prescribing Trends of the Sodium-Glucose Cotransporter-2 Inhibitors Among Different Physician Specialties in Canada (2015-2021)Wajd Alkabbani, John-Michael Gamble
Pageof 98